Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/12/2025 | 31/12/2024 |
|---|---|---|
| Revenue | 140M | 64M |
| Research and development | 410M | 368M |
| Selling, general and administrative | 114M | 112M |
| Operating expenses | 523M | 479M |
| Operating income | −384M | −416M |
| Pre-tax income | −80M | −377M |
| Income tax | 0 | 39,000 |
| Net income | −80M | −377M |
| Earnings per share | −0.81 | −4.58 |
| Earnings per share, diluted | −0.81 | −4.58 |
| Weighted average shares | 99M | 82M |
| Weighted average shares, diluted | 99M | 82M |
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 288M | 295M | 268M | 282M | 528M | 282M | 230M | 293M |
| Short-term investments | 923M | 950M | 807M |
| Metric | 31/12/2025 | 31/12/2024 |
|---|---|---|
| Operating cash flow | −345M | −347M |
| Depreciation and amortisation | 22M | 22M |
| Share-based compensation | 94M | 121M |
| Capital expenditure | 15M | 9M |
| Investing cash flow | −121M | 185M |
| Financing cash flow | 478M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 868M |
| 692M |
| 569M |
| 696M |
| 715M |
| Current assets | 1.27B | 1.27B | 1.10B | 1.18B | 1.25B | 878M | 946M | 1.03B |
| Property, plant and equipment | 101M | 105M | 108M | 109M | 110M | 111M | 114M | 117M |
| Total assets | 1.48B | 1.48B | 1.31B | 1.39B | 1.47B | 1.10B | 1.17B | 1.26B |
| Current liabilities | 75M | 97M | 183M | 174M | 142M | 182M | 166M | 177M |
| Long-term debt | 100M | — | — | — | — | — | — | — |
| Total liabilities | 316M | 243M | 345M | 344M | 344M | 370M | 380M | 407M |
| Equity | 1.16B | 1.24B | 966M | 1.05B | 1.12B | 734M | 791M | 854M |
| Shares outstanding | 103M | 102M | 101M | 101M | 101M | 84M | 83M | 82M |
| Shares issued | 103M | 102M | 101M | 101M | 101M | 84M | 83M | 82M |
| 8M |